Literature DB >> 26859801

Racial Differences in Receipt of Chlamydia Testing Among Medicaid-Insured Women in 2013.

Chirag G Patel1, Harrell W Chesson, Guoyu Tao.   

Abstract

OBJECTIVE: To estimate the percentage of young, sexually active Medicaid-insured women who were tested for chlamydia by age, race/ethnicity, and history of sexually transmitted disease (STD) diagnosis.
METHODS: We used the medical diagnostic and procedural codes from Truven Health MarketScan Medicaid claims data from 10 states in 2012 and 2013 to estimate the rates of chlamydia testing in 2013 and previous STD diagnosis (diagnosed in 2012) among Medicaid-insured women aged 15-25 years who were sexually active in 2013. We also used a logit model to assess the association between chlamydia testing and women's age, race/ethnicity, and previous STD diagnosis.
RESULTS: Overall, among approximately 261,000 Medicaid-insured women aged 15-25 years in 2013 who were classified as sexually active, 50.2% were tested for chlamydia in 2013. The chlamydia testing rate was 45.6% for white women and 57.5% for black women. The chlamydia testing rate was 63.5% for women diagnosed as having an STD in 2012 and 46.8% for women not diagnosed as having an STD in 2012. The chlamydia testing rate was significantly (P < 0.05) associated with previous STD diagnosis, age, and race/ethnicity in our logit model.
CONCLUSIONS: Higher chlamydia testing rates among black women can be explained in part by higher rates of previous STD diagnoses. Our finding that black women have the highest chlamydia testing rates is encouraging, as improved access to STD prevention services among racial/ethnic minorities can help to reduce racial/ethnic disparities in STDs. However, chlamydia screening remains an underused preventive health service for young women of all racial and ethnic groups.

Entities:  

Mesh:

Year:  2016        PMID: 26859801      PMCID: PMC6784822          DOI: 10.1097/OLQ.0000000000000405

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  25 in total

Review 1.  Risk of sequelae after Chlamydia trachomatis genital infection in women.

Authors:  Catherine L Haggerty; Sami L Gottlieb; Brandie D Taylor; Nicola Low; Fujie Xu; Roberta B Ness
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

2.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

3.  Chlamydia screening among females aged 15-21 years--multiple data sources, United States, 1999-2010.

Authors:  Karen W Hoover; Jami S Leichliter; Elizabeth A Torrone; Penny S Loosier; Thomas L Gift; Guoyu Tao
Journal:  MMWR Suppl       Date:  2014-09-12

4.  Estimating chlamydia screening coverage: a comparison of self-report and health care effectiveness data and information set measures.

Authors:  Christine M Khosropour; Jennifer M Broad; Delia Scholes; Jacquelyn Saint-Johnson; Lisa E Manhart; Matthew R Golden
Journal:  Sex Transm Dis       Date:  2014-11       Impact factor: 2.830

5.  Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial.

Authors:  Pippa Oakeshott; Sally Kerry; Adamma Aghaizu; Helen Atherton; Sima Hay; David Taylor-Robinson; Ian Simms; Phillip Hay
Journal:  BMJ       Date:  2010-04-08

6.  Chlamydia screening of young sexually active, Medicaid-insured women by race and ethnicity, 2002-2005.

Authors:  Lauren Christiansen-Lindquist; Guoyu Tao; Karen Hoover; Robbie Frank; Charlotte Kent
Journal:  Sex Transm Dis       Date:  2009-10       Impact factor: 2.830

Review 7.  Chlamydia and gonorrhea screening in United States emergency departments.

Authors:  Wiley D Jenkins; Whitney Zahnd; Regina Kovach; Patricia Kissinger
Journal:  J Emerg Med       Date:  2012-10-26       Impact factor: 1.484

8.  High frequencies of negative pretreatment results following presumptive antibiotic treatment for chlamydia and gonorrhea.

Authors:  Belma Andric; Joanna Drowos; Mary Jo Trepka; Gabriel Suciu; Alina Alonso; Charles H Hennekens
Journal:  South Med J       Date:  2013-05       Impact factor: 0.954

9.  Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results.

Authors:  L Weström; R Joesoef; G Reynolds; A Hagdu; S E Thompson
Journal:  Sex Transm Dis       Date:  1992 Jul-Aug       Impact factor: 2.830

10.  Understanding sexual activity and Chlamydia testing rate based on linked national survey and Medicaid claims data.

Authors:  Guoyu Tao; Jennifer Hua; Jessica L Chen
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

View more
  5 in total

1.  Racial/Ethnic Disparities in the Lifetime Risk of Chlamydia trachomatis Diagnosis and Adverse Reproductive Health Outcomes Among Women in King County, Washington.

Authors:  Laura C Chambers; Christine M Khosropour; David A Katz; Julia C Dombrowski; Lisa E Manhart; Matthew R Golden
Journal:  Clin Infect Dis       Date:  2018-08-01       Impact factor: 9.079

2.  Gonorrhea and Chlamydia Testing and Case Rates Among Women Veterans in the Veterans Health Administration.

Authors:  Shimrit Keddem; Marissa Maier; Carolyn Gardella; Joleen Borgerding; Elliott Lowy; Maggie Chartier; Sally Haskell; Ronald G Hauser; Lauren A Beste
Journal:  J Gen Intern Med       Date:  2022-08-30       Impact factor: 6.473

3.  Disparities in state-mandated third-trimester testing for syphilis.

Authors:  Amelia C Clement; Kathryn E Fay; Lynn M Yee
Journal:  Am J Obstet Gynecol MFM       Date:  2022-02-15

4.  Sexually transmissible infection testing among pregnant women in the US, 2011-15.

Authors:  Jami S Leichliter; Laura T Haderxhanaj; Thomas L Gift; Patricia J Dittus
Journal:  Sex Health       Date:  2020-02       Impact factor: 2.706

5.  National racial/ethnic and geographic disparities in experiences with health care among adult Medicaid beneficiaries.

Authors:  Steven C Martino; Megan Mathews; Denis Agniel; Nate Orr; Shondelle Wilson-Frederick; Judy H Ng; A Elizabeth Ormson; Marc N Elliott
Journal:  Health Serv Res       Date:  2019-01-09       Impact factor: 3.402

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.